Home Based Infusions for Ocrelizumab

This trial looks at whether receiving ocrelizumab (an MS infusion medication) at home is as safe and effective as receiving it in a clinic setting, for people with multiple sclerosis in the Denver, Colorado area. **You may be eligible if...** - You are 18–55 years old and a current patient at Rocky Mountain MS Center - You have been diagnosed with relapsing or primary progressive MS - You have already received your first 600 mg ocrelizumab infusion - You live in the Denver metro, Fort Collins, or Colorado Springs area - Your neurologist believes continuing ocrelizumab is appropriate for you **You may NOT be eligible if...** - You are pregnant, planning to become pregnant, or breastfeeding - You have previously participated in the SaROD trial at this center - Your lab results are not suitable for home infusion in your doctor's judgment Talk to your doctor to see if this trial is right for you.